Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

Overview of attention for article published in PLOS ONE, June 2012

Altmetric Badge

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 83 Mendeley
citeulike: 1 CiteULike

Summary Dimensions citations

So far, Dimensions has found 53 publications that cite this research output.

53

The most recent citing publications are shown below. View all 53 publications that cite this research output on Dimensions.

Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with early breast cancer: A hellenic cooperative oncology group observational study (HE 10/10) with concurrent investigation of significance of tumor infiltrating lymphocytes

Article in The Breast (December 2023)

Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study

Article in Cancers (November 2022)

Utility of Personalized Medicine in the Treatment of Different Subtypes of Breast Cancer

Book chapter (May 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.